Old Web
English
Sign In
Acemap
>
authorDetail
>
Jasmine Rutecki
Jasmine Rutecki
Amicus Therapeutics
Genetics
Migalastat
Diabetes mellitus
Fabry disease
Observational study
3
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Baseline patient characteristics of followME, a new, patient-centric, prospective, observational Fabry disease registry that evaluates migalastat, ERT, and a natural history cohort
2020
Molecular Genetics and Metabolism
Gere Sunder-Plassmann
Daniel G. Bichet
Martynas Davidonis
Dominique P. Germain
Roberto Giugliani
Robert J. Hopkin
Ana Jovanovic
Ales Linhart
Kathleen Nicholls
Peter Nordbeck
Ulla Feldt-Rasmussen
Jasmine Rutecki
Joe Giuliano
Nina Skuban
Eva Krusinska
Juan Politei
Show All
Source
Cite
Save
Citations (0)
Design of a prospective, multicenter, multinational, observational safety and outcomes registry in Fabry disease patients treated with migalastat and untreated patients
2019
Molecular Genetics and Metabolism
Gere Sunder-Plassmann
Daniel G. Bichet
Martynas Davidonis
Dominique P. Germain
Roberto Giugliani
Robert J. Hopkin
Ana Jovanovic
Ales Linhart
Kathleen Nicholls
Peter Nordbeck
Ulla Feldt-Rasmussen
Jasmine Rutecki
Joe Giuliano
Nina Skuban
Juan Politei
Show All
Source
Cite
Save
Citations (0)
Long-term efficacy and safety of migalastat compared to enzyme replacement therapy in Fabry disease: Phase 3 study results
2015
Molecular Genetics and Metabolism
Derralynn Hughes
Daniel G. Bichet
Roberto Giugliani
Raphael Schiffmann
William R. Wilcox
Elfrida R. Benjamin
Jeffrey P. Castelli
John Kirk
Jasmine Rutecki
Nina Skuban
Julie Yu
Jay Barth
Show All
Source
Cite
Save
Citations (3)
1